How do I compare drug manufacturers general stocks?

Compare using valuation ratios (P/E, P/B, EV/EBITDA), profitability metrics, growth rates, and financial health indicators. Direct comparison within the same industry provides meaningful insights.

What to consider when investing in drug manufacturers general stocks?

Consider industry trends, competitive positioning, valuation relative to peers, financial strength, management quality, and dividend sustainability for income-focused investments.

Drug Manufacturers General Stocks - Companies, Performance & Financial Metrics

Q: How many stocks are in the drug manufacturers general industry?

There are 20 publicly traded stocks in the drug manufacturers general industry, part of the Healthcare sector.

Browse 20 drug manufacturers general stocks with financial metrics and performance data (Healthcare sector).

Drug Manufacturers General Stocks

20 stocks in the drug manufacturers general industry. Click column headers to sort.

#
1	LLY	Eli Lilly and Company	$1,036.05	$930.37B	$59.42B	$18.41B	$20.49	2.96M
2	AZN	AstraZeneca PLC	$209.48	$654.00B	$58.13B	$9.40B	$3.01	2.29M
3	JNJ	Johnson & Johnson	$243.33	$591.15B	$92.15B	$25.12B	$10.34	11.84M
4	ABBV	AbbVie Inc.	$232.86	$412.63B	$59.64B	$2.39B	$1.35	7.33M
5	NVS	Novartis AG	$166.17	$324.86B	$56.67B	$13.98B	$7.25	2.41M
6	MRK	Merck & Co., Inc.	$121.57	$304.78B	$65.01B	$18.25B	$7.34	9.81M
7	NVO	Novo Nordisk A/S	$49.37	$219.59B	$48.88B	$16.20B	$3.64	9.85M
8	AMGN	Amgen Inc.	$373.36	$202.36B	$36.75B	$7.71B	$14.20	2.20M
9	GILD	Gilead Sciences, Inc.	$155.27	$194.55B	$29.44B	$8.51B	$6.79	5.88M
10	PFE	Pfizer Inc.	$27.37	$155.63B	$62.58B	$7.77B	$1.37	32.06M
11	GSK	GSK plc	$60.87	$125.30B	$44.13B	$7.74B	$3.79	5.66M
12	SNY	Sanofi	$46.43	$113.33B	$55.32B	$9.25B	$3.79	5.33M
13	BIIB	Biogen Inc.	$195.62	$28.70B	$9.89B	$1.29B	$8.82	968.51K
14	GRFS	Grifols, S.A.	$9.55	$6.50B	$8.91B	$431.86M	$0.63	522.75K
15	OGN	Organon & Co.	$7.28	$1.90B	$6.30B	$501.00M	$1.92	3.79M
16	AMRN	Amarin Corporation plc	$15.64	$324.95M	$226.73M	-$86.19M	$-4.15	155.20K
17	SCLX	Scilex Holding Company	$8.07	$93.64M	$40.36M	-$332.08M	$-28.62	25.62K
18	NSRX	Nasus Pharma Ltd.	$5.96	$50.52M	—	-$1.53M	$-0.22	1.41K
19	MIRA	MIRA Pharmaceuticals, Inc.	$1.25	$24.09M	$0.00	-$28.42M	$-1.47	180.65K
20	MDCX	Medicus Pharma Ltd.	$1.10	$20.49M	$0.00	-$29.53M	$-1.59	268.13K

About the Drug Manufacturers General Industry

The Drug Manufacturers General industry comprises 20 publicly traded companies within the Healthcare sector that share similar business models and competitive dynamics.

Company Types

- Industry leaders with market share and scale
- Growth companies expanding rapidly
- Value opportunities below peer averages
- Dividend payers for income investors

Key Considerations

- Compare valuation ratios to industry peers
- Assess competitive positioning and moats
- Monitor regulatory and technology trends
- Evaluate financial health and cash flow